Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DISOPYRAMIDE vs DOCETAXEL ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DISOPYRAMIDE vs DOCETAXEL ANHYDROUS: Safety Overview

Metric DISOPYRAMIDE DOCETAXEL ANHYDROUS
Total FAERS Reports 619 1,084
Deaths Reported 23 5
Death Rate 3.7% 0.5%
Hospitalizations 113 10
Average Patient Age 66.5 yrs 55.6 yrs
% Female Patients 67.7% 99.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Mylan Pharmaceuticals Inc. Mylan Institutional LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A